Loading data
VIVSNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 131 k USD | 144 k USD | 109 k USD | 370 k USD | 1.5 m USD |
| Cost of revenue | 0 USD | 5 k USD | — | — | — |
| Research and development expense | 4.19 m USD | 5.03 m USD | 5.5 m USD | 8.89 m USD | 3.32 m USD |
| Selling, general and administrative expense | 7.43 m USD | 7.73 m USD | 9.7 m USD | 9.22 m USD | 9.66 m USD |
| Operating profit | -11.49 m USD | -12.62 m USD | -15.09 m USD | -17.73 m USD | -11.48 m USD |
| Profit before tax | -13.84 m USD | -2.49 m USD | — | — | — |
| Income tax expense | 2 k USD | 2 k USD | 2 k USD | 2 k USD | 2 k USD |
| Net income (reported basis) | -13.84 m USD | -2.49 m USD | -14.67 m USD | -17.26 m USD | -11.45 m USD |
| Basic earnings per share | -5.35 USD/share | -1.7 USD/share | -19.25 USD/share | -1.98 USD/share | -1.32 USD/share |
| Diluted earnings per share | -5.35 USD/share | -1.7 USD/share | -19.25 USD/share | -1.98 USD/share | -1.32 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.